Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 4, 2012, Pages 334-339

  Chennupati, Sravana K ^a   Quon, Andrew ^a   Kamaya, Aya ^a   Pai, Reetesh K ^a   La, Trang ^a   Krakow, Trevor E ^a   Graves, Edward ^a   Koong, Albert C ^a   Chang, Daniel T ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

neoadjuvant chemoradiation; pathologic response; PET response; rectal cancer

Indexed keywords

FLUOROURACIL;

ADJUVANT THERAPY; ARTICLE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; HUMAN; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RECTUM CANCER; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR REGRESSION; TUMOR VOLUME;

ADENOCARCINOMA; CHEMORADIOTHERAPY; FLUORODEOXYGLUCOSE F18; HUMANS; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS;

EID: 84864353779     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182118d12     Document Type: Article

References (31)

1. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: national surgical adjuvant breast and bowel project protocol R-02. J Natl Cancer Inst. 2000;92:388-396. (Pubitemid 30154820)
2. Swedish rectal cancer trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980-987.
3. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
4. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
5. Wagman R, Minsky BD, Cohen AM, et al. Conservative management of rectal cancer with local excision and postoperative adjuvant therapy. Int J Radiat Oncol Biol Phys. 1999;44:841-846. (Pubitemid 29284133)
6. Bonnen M, Crane C, Vauthey JN, et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys. 2004;60: 1098-1105. (Pubitemid 39440794)
7. Kim CJ, Yeatman TJ, Coppola D, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg. 2001;234:352-358; discussion 358-359.
8. Mohiuddin M, Marks G, Bannon J. High-dose preoperative radiation and full thickness local excision: A new option for selected T3 distal rectal cancers. Int J Radiat Oncol Biol Phys. 1994;30:845-849. (Pubitemid 24355935)
9. Schell SR, Zlotecki RA, Mendenhall WM, et al. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg. 2002;194:584-590; discussion 590-591.
10. Borschitz T, Wachtlin D, Mohler M, et al. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol. 2008;15:712-720.
11. Biggers OR, Beart RW Jr, Ilstrup DM. Local excision of rectal cancer. Dis Colon Rectum. 1986;29:374-377. (Pubitemid 16057743)
12. Killingback M. Local excision of carcinoma of the rectum: Indications. World J Surg. 1992;16:437-446.
13. Marks G, Mohiuddin MM, Masoni L, et al. High-dose preoperative radiation and full-thickness local excision: A new option for patients with select cancers of the rectum. Dis Colon Rectum. 1990;33:735-739. (Pubitemid 20308158)
14. Janjan NA, Abbruzzese J, Pazdur R, et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol. 1999;51:153-160. (Pubitemid 29320309)
15. Vecchio FM, Valentini V, Minsky BD, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys. 2005;62:752-760. (Pubitemid 40779765)
16. Amthauer H, Denecke T, Rau B, et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging. 2004;31:811-819. (Pubitemid 38758350)
17. Capirci C, Rampin L, Erba PA, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neoadjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging. 2007;34:1583-1593. (Pubitemid 47476915)
18. Kristiansen C, Loft A, Berthelsen AK, et al. PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer. Dis Colon Rectum. 2008;51:21-25.
19. Rosenberg R, Herrmann K, Gertler R, et al. The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis. 2009;24:191-200.
20. Janssen MH, Ollers MC, Riedl RG, et al. Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucosepositron emission tomography-computed tomography imaging. Int J Radiat Oncol Biol Phys. 2010;77:392-399.
21. Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
22. Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47:141-146. (Pubitemid 41113116)
23. Lee P, Weerasuriya DK, Lavori PW, et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007;69:328-333. (Pubitemid 47380105)
24. Melton GB, Lavely WC, Jacene HA, et al. Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg. 2007;11:961-999; discussion 969.
25. Denecke T, Rau B, Hoffmann KT, et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? Eur Radiol. 2005;15: 1658-1666. (Pubitemid 41102362)
26. Guillem JG, Moore HG, Akhurst T, et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining longterm outcomes of rectal cancer J Am Coll Surg. 2004;199:1-7. (Pubitemid 38813288)
27. Cascini GL, Avallone A, Delrio P, et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med. 2006;47:1241-1248. (Pubitemid 47544874)
28. Terasawa T, Lau J, Bardet S, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large Bcell lymphoma: A systematic review. J Clin Oncol. 2009;27: 1906-1914.
29. Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial. Lancet Oncol. 2007;8:797-805. (Pubitemid 47308659)
30. Murphy JD, La TH, Chu K, et al. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jun 18. [epub]. Pubmed ID is 20646870.
31. Greven KM, Williams DW III, McGuirt WF Sr, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001;23: 942-946. (Pubitemid 32977536)